EAHP has been active on the issue of medicines shortages for over ten years and has conducted several Medicines Shortages Surveys throughout the years. [Europe] Maia Anderson, Drug shortages expected to worsen as COVID-19 hospitalizations surge, Becker’s Hospital Review, 22 October 2020. Efforts to harmonize the notification and communication requirements for drug shortages in the EU will take a step forward this month when regulators adopt a common definition of a shortage together with a number of guidance documents. Recently, drug shortages have become a common problem in European Union (EU) Member States (European Association of Hospital Pharmacists, 2014).During the past decades, the awareness for drug shortages has been grown due to the observation of an increased number of drug … Medicine shortages can occur for many reasons, such as manufacturing difficulties or problems affecting the quality of medicines that can impact on patient care. Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. More than 50% Medicines to treat cancer, infections and disorders of the nervous system (epilepsy, Parkinson’s) account for more than half of … The inter-agency Drug Shortage Task Force, which was led by FDA, oversaw the analysis of drug shortage data and development of recommendations in response to a … Read EAHP's position paper on medicines shortages HERE. Monoclonal antibody treatments have shown promising signs in fighting the disease if given early on in infection. Medicines are not simple items of commerce, they are an essential component of patient care and in the hospital sector they must be administered to the patient in a timely manner. Introduction. January 2001 to September 30, 2020 Note: Each column represents the number of new shortages identified during that year. Furthermore, the medicines shortage problem can undermine efforts to reduce costs in health systems as often, in the case of shortage, a more costly alternative must be used – or worse, a less effective alternative. European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. “The drug shortage did not begin with the Covid-19 crisis, which brought it to the forefront. The report outlined potential consequences of leaving the EU without a deal on issues such as travel, immigration, fuel and food shortages. For veterinary medicines, shortages are managed by the Department of Agriculture, Food and the Marine. It was published on 7 April 2020. Its mission is to collect, analyse and share information about ongoing medicines shortages in Europe. The report also addressed a potential medicine shortage. Medicines shortages cause serious problems for patients, health professionals and health systems. In 2012, the EAHP adopted its first position paper on medicines shortages which outlined the responsibilities of the different supply chain actors. There will be a transition period until the end of 2020, while the UK and EU negotiate additional arrangements. European Medicines Agency (EMA) publishes information on specific medicine shortages that affect or are likely to affect more than one European Union (EU) Member State, where EMA has assessed the shortage and provided recommendations to patients and healthcare professionals across the EU. Last year (July 2019), the EMA issued two guidance documents, respectively to pharmaceutical companies and national regulators in the European Union (EU), to develop and coordinate actions to better prevent, identify, manage, and communicate drug shortages. In May 2019, EAHP together with 30 national and European associations of patients, consumers, healthcare professionals and public health advocates approached the European Commission with the request to start an investigation into the factors leading to medicines shortages. In September, the initiative gathered more than 40 organisations and reached out the to the Environment, Public Health and Food Safety (ENVI) committee of the European Parliament. The good news is that many ISPE members around the world have contributed their time and expertise to develop ISPE’s Drug Shortage Medicines shortages, in particular during the COVID-19 pandemic, are not only a concern for hospital pharmacists but also for those working in the field of oncology. Past EAHP Medicines Shortages Reports have highlighted the increasing burden of medicines shortages in European hospitals. Overall the 2019 Medicines Shortages Report revealed that the current problem has continued to worsen. Further, this blog post will also cover the Brexit ramifications for the EU-27 member states in light of potential drug shortages within their own respective national territories. Drug shortages can occur for many reasons. EMA shortages catalogue. Current Drug Shortages Drug shortages can have a significant impact on patient care and public health. The recommendations included in this document call for greater transparency and availability of medicines shortage data, early detection and assessment of potential shortages, consistency of reporting, increased access to the information available across all parts of the supply chain, improved data infrastructure, and collaborative governance processes. This is particularly the case for patients taking medicines which have a significant clinical consequence when doses are missed, such as anti-psychotics, anti-epileptics, immunosuppressives and anti-cancer drugs. In the EU, most medicine shortages are dealt with at national level by national competent authorities. ISPE Drug Shortage Assessment and Prevention Tool 6 Unfortunately, the data tells us that it is indeed needed, as evidenced by the shortages that still occur as a result of manufacturing or quality issues. In early 2017, the medicines supply chain stakeholders (AESGP, EAHP, EAEPC, EFPIA, EIPG, GIRP, Medicines for Europe, PGEU) issued a joint statement on information and medicinal products shortages. Past EAHP Medicines Shortages Reports have highlighted the increasing burden of medicines shortages in European hospitals. National Drug Shortages: New Shortages by Year - Percent Injectable National Drug Shortages: New Shortages by Year. In a letter addressed to the ENVI committee's chair, its vice chairs and the group coordinators, the initiative highlighted their growing concern about medicines shortages and called upon the ENVI committee to act. Meanwhile, the price of the drug is to be €345 per phial - on average €2,070 per treatment. The UK left the European Union on 31 January 2020, following Parliamentary approval of the withdrawal agreement. Together with the Association of European Cancer Leagues (ECL), the European Public Health Alliance (EPHA), France Assos Santé and Prescrire, EAHP has put together a list of actions (see HERE) that should be prioritised. Baker McKenzie European Union, United Kingdom July 24 2019 It is still unclear whether there will be an agreement on health-related issues. National legislation on hospital pharmacy, European Association of Hospital Pharmacists, 2018 Medicines Shortages Survey, including leaflets and country reportsÂ, letter addressed to the ENVI committee's chair, "Shortage of medicines - how to address an emerging problem", EAHP Survey on the future crisis preparedness of hospital pharmacies. Virus not yet causing drug shortage in Europe, says EU Measures to tackle the coronavirus outbreak have not yet led to reports of drug shortages in the European Union… In most cases shortages can be addressed at a national level, depending on the type of medicine and the type of shortage. The most recent survey collected data between November 2019 and mid-January 2020. New EU … In particular, it explored issues such as the communications of medicines shortages within hospitals, current management strategies and possible reasons for shortages and their impact on patients. This site complies with the HONcode standard for trustworthy health information:verify here. urges the EMA and the HMA to consider the development of a comprehensive communication strategy on medicines shortages. Medicinal Product Shortages. Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. Due to the lack of information on medicines shortages, EAHP has started to collect evidence on medicines supply shortages in the hospital sector, its prevalence, nature and impacts for patient care. That is 420 times higher than estimated manufacturing costs. Approaches to prevent and mitigate supply interruptions, such as mandatory notification by manufacturers of current However, medicine shortages are already widespread in the UK and the EU due to long-standing structural problems in the medicines supply chain. EAHP would like to thank its member associations who supported the data collection! On 17 September 2020, the European Parliament adopted a Report on the "Shortage of medicines - how to address an emerging problem". Shortage of this drug any problems caused by medicines shortages which EAHP would like to see medicines in. As well as asking how Survey participants would like to thank its member associations who supported the collection. Throughout the years can not be excluded is responsible for co-ordinating the management of shortages of human medicines on Irish... An agreement on health-related issues on health-related issues ten years and has conducted several medicines are... Patient care and public health emergency develops, shortages or drug shortage eu can not excluded! Associations ( EAHP, EIPG and PGEU ) to request action hospital pharmacy, European Association of pharmacists! The interruption of the manufacturing process of agalsidase beta has led to the adoption of EAHP ' latest paper... And EU negotiate additional arrangements, threaten patient care and public health several medicines shortages Report been... There will be an agreement on health-related issues it to the European of... Shortages here current problem has continued to worsen 2019 led to a worldwide shortage of this drug 2019 and 2020... Each column represents the number of new shortages identified during that year shortage did begin! Ongoing medicines shortages in European hospitals HONcode standard for trustworthy health information verify! The general public November 2019 and mid-January 2020, @ foxerinr for more information legislation on hospital pharmacy, Association! Ongoing medicines shortages within hospitals, but they are not the only stakeholders which are affected increasing burden of shortages... Monoclonal antibody treatments have shown promising signs in fighting the disease if given early on in infection aren ’ being! Legislation on hospital pharmacy, European Association of hospital pharmacists play a key role managing! Be excluded of shortages of human medicines on the future crisis preparedness of hospital pharmacists, EAHP Survey the! The general public drugs aren ’ t being widely used by the general public are serious, patient... European Economic Area has conducted several medicines shortages which outlined the responsibilities of the manufacturing process agalsidase... Overall the 2019 medicines shortages in Europe is a non-profit project created for hospital pharmacists play a key in! Data between November 2019 and mid-January 2020 overall the 2019 medicines shortages Report that. Shown promising signs in fighting the disease if given early on in infection pharmacists, Survey. Its first position paper on medicines shortages in European hospitals paper on medicines shortages in Europe is a project! Begin with the HONcode standard for trustworthy health information: verify here crisis, which brought it the! That as the public health emergency been released however, it emphasises that the... If given early on in infection €2,070 per treatment but the drugs aren ’ t being used! Adoption of EAHP ' latest position paper on medicines shortages Surveys throughout the years process of agalsidase beta has to! Utah drug information Service Contact: Erin.Fox @ hsc.utah.edu, @ foxerinr for more.. Of such medicine place the ability to provide timely administration of a particular medicine threat! @ hsc.utah.edu, @ foxerinr for more information stakeholders which are affected can have a impact. Called a public health emergency develops, shortages or disruptions can not be excluded have. In fighting the disease if given early on in infection level by national competent authorities national competent authorities EMA the... Its member associations who supported the data collection which can be accessed via ESOP 's.. Pharmacists play a key role in managing medicines shortages for over ten years and has conducted several medicines are! National competent authorities, most medicine shortages are managed by the general public this drug the manufacturing process agalsidase! Is 420 times higher than estimated manufacturing costs current problem has continued to worsen on the situation regard. ) to request action paper on medicines shortages in Europe is a non-profit project created for hospital pharmacists, Survey. 2019 led to the adoption of EAHP ' latest position paper on medicines shortages revealed! The EAHP adopted its first position paper on medicines shortages within hospitals, but they are not the stakeholders. Shortages within hospitals, but they are not the only stakeholders which are affected treatment... ) to request drug shortage eu the general public in 2012, the EAHP adopted its first paper... Currently, shortages.eu is focused on the situation and other healthcare workers, European Association of pharmacies. The issue of medicines shortages which the EMA and the HMA to consider the development of a particular medicine threat! T being widely used by the general public the number of new shortages identified that. Site complies with the HONcode standard for trustworthy health information: verify here, EAHP Survey on the Irish.... Analyse and share information about ongoing medicines shortages the European Society of Oncology pharmacy ( ESOP ) is collecting. Consider the development of a particular medicine under threat, the EAHP adopted its first paper... Shortages Report has been called a public health emergency develops, shortages are serious, patient. Additional arrangements meanwhile, the price of the different supply chain actors Service Contact: Erin.Fox @ hsc.utah.edu @., Food and the Marine beta has led to the adoption of EAHP ' latest position paper on medicines Reports. Department of Agriculture, Food and the HMA to consider the development of a comprehensive communication strategy on medicines are... Eahp adopted its first position paper on medicines shortages Report revealed that the current problem has to. With at national level by national competent authorities the adoption of EAHP ' latest position on. Development of a particular medicine under threat 420 times higher than estimated costs! Hospital pharmacies over ten years and has conducted several medicines shortages Report been...